Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Hypertriglyceridemia in the Genomic Era: A New Paradigm

Abstract

Hypertriglyceridemia (HTG) is a highly prevalent condition that is associated with increased cardiovascular disease risk. HTG may arise as a result of defective metabolism of triglyceride-rich lipoproteins and their remnants, ie, impaired clearance, or increased production, or both. Current categorization of HTG segregates primary and secondary cases, implying genetic and nongenetic causes for each category. Many common and rare variants of the genes encoding factors involved in these pathways have been identified. Although monogenic forms of HTG do occur, most cases are polygenic and often coexist with nongenetic conditions. Cumulative, multiple genetic variants can increase the risks for HTG, whereas environmental and lifestyle factors can force expression of a dyslipidemic phenotype in a genetically susceptible person. HTG states are therefore best viewed as a complex phenotype resulting from the interaction of cumulated multiple susceptibility genes and environmental stressors. In view of the heterogeneity of the HTG states, the absence of a unifying metabolic or genetic abnormality, overlap with the metabolic syndrome and other features of insulin resistance, and evidence in some patients that accumulation of numerous small-effect genetic variants determines whether an individual is susceptible to HTG only or to HTG plus elevated low-density lipoprotein cholesterol, we propose that the diagnosis of primary HTG and further delineation of familial combined hyperlipidemia from familial HTG is neither feasible nor clinically relevant at the present time. The hope is that with greater understanding of genetic and environmental causes and their interaction, therapy can be intelligently targeted in the future.

Overview

Integrity signals

Registry

Crossref · 10.1210/er.2014-1062

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 113 references

Cited by

See all 152

Metadata

Authors
Lewis, G. F., Xiao, C., & Hegele, R. A.
Affiliations
  • University of Toronto (CA)
  • Western University (CA)
Corresponding author
Lewis, Gary F.
Venue
Endocrine Reviews
Published
2015-02-01
Volume
36
Issue
1
Pages
131-147
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2142850613
Cited by
152
References
113
Citations by year
2026: 4 · 2025: 4 · 2024: 14 · 2023: 9 · 2022: 14 · 2021: 19 · 2020: 22 · 2019: 17 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 8
FWCI
2.76
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • Genome Canada
  • Canadian Institutes of Health Research (79533, MOP‑79533), MOP13430, MOP-43839)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
hypertriglyceridemia, triglyceride-rich lipoproteins, remnant lipoproteins, genetic susceptibility, polygenic inheritance, familial combined hyperlipidemia, familial hypertriglyceridemia, metabolic syndrome, insulin resistance, LDL cholesterol, gene-environment interaction, cardiovascular risk, dyslipidemia
MeSH terms
Alcohol Drinking, Diabetes Mellitus, Type 2, Environment, Female, Humans, Insulin Resistance, Life Style, Lipoproteins, Male, Metabolic Clearance Rate, Middle Aged, Nephrotic Syndrome, Phenotype, Pregnancy, Pregnancy Complications, Risk Factors, Triglycerides, Genetic Variation, Hypertriglyceridemia, Genetic Predisposition to Disease, Metabolic Syndrome, Atherosclerosis, Renal Insufficiency, Chronic, Obesity, Abdominal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypertriglyceridemia in the Genomic Era: A New Paradigm. https://app.cochat.ai/papers/10.1210/er.2014-1062
The paper
Lewis, G. F., Xiao, C., & Hegele, R. A. (2015). Hypertriglyceridemia in the Genomic Era: A New Paradigm. Endocrine Reviews. https://doi.org/10.1210/er.2014-1062

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.